Expert Review of Anticancer Therapy期刊在2020-2022连续三年的影响因子维持在3分以上, 略微有所波动, 分别为4.512分, 3.627分, 3.3分。 3、分区 Expert Review of Anticancer Therapy期刊在JCR分区中被归为Q3区。 Expert Review of Anticancer Therapy期刊在中科院分区中被分类为 大类学科 医学: 3区; 小类学科 ...
Expert Review of Anticancer Therapy (ISSN 1473-7140) provides expert appraisal and commentary on the major trends in cancer care and highlights the performance of new therapeutic and diagnostic approaches. Coverage includes tumor management, novel medicines, anticancer agents and chemotherapy, biological ...
②Expert Review of Anticancer Therapy的自引率先降后升,但不高,2023年度为3%。 ③Expert Review of Anticancer Therapy最近五年发文量分别为113,83,122,99,106。 目前,发文量占比最大的国家为美国,我国国人发文138篇,占比3.7%。 ④综合来看,Expert Review of Anticancer Therapy发文量一般、影响因子稳定,国人占...
《抗癌治疗专家评论》(Expert Review Of Anticancer Therapy)是一本以医学-肿瘤学综合研究为特色的国际期刊。该刊由Taylor and Francis Ltd.出版商创刊于2001年,刊期Bimonthly。该刊已被国际重要权威数据库SCIE收录。期刊聚焦医学-肿瘤学领域的重点研究和前沿进展,及时刊载和报道该领域的研究成果,致力于成为该领域同行进...
Expert Review Of Anticancer Therapy 偏慢,4-8周审稿时间 3区中科院分区 Q2JCR分区 2.9影响因子 ISSN:1473-7140 E-ISSN:1744-8328 国际简称:EXPERT REV ANTICANC 出版国家或地区:ENGLAND 研究方向:医学 - 肿瘤学 是否预警:否 创刊时间:2001 H-index:59 ...
expert review of anticancer therapy current approaches for identifying high-risk non- muscle invasive bladder cancer current approaches for identifying high-risk non-muscle invasive bladder cancerBladder cancer is a highly prevalent disease and is associated with substantial morbidity, mortality and cost. ...
Expert Review of Anticancer Therapy (ISSN 1473-7140) provides expert appraisal and commentary on the major trends in cancer care and highlights the performance of new therapeutic and diagnostic approaches. Coverage includes tumor management, novel medicines, anticancer agents and chemotherapy, biological ...
《Expert Review Of Anticancer Therapy》(《抗癌治疗专家评论》)是一本由Taylor and Francis Ltd.出版的医学-肿瘤学学术刊物,主要刊载医学-肿瘤学相关领域研究成果与实践,旨在打造一种学术水平高、可读性强、具有全球影响力的学术期刊。本刊已入选SCIE来源期刊。该刊创刊于2001年,出版周期Bimonthly。2023年发布的影响...
期刊ISSN1473-7140 期刊全称Expert Review Of Anticancer Therapy 期刊缩写Expert Rev Anticanc 影响因子2.212 自引率2.20% SCI 收录情况SCIE收录; ESI 学科分类临床医学(Clinical Medicine) 中科院大类分区医学:4区 中科院小类分区肿瘤学4区 是否Top期刊否
期刊简称EXPERT REV ANTICANC 参考译名《抗癌治疗专家评论》 核心类别SCIE(2022版), 目次收录(知网),外文期刊, IF影响因子 自引率 主要研究方向医学-ONCOLOGY肿瘤学 Expert Review of Anticancer Therapy《抗癌治疗专家评论》(月刊). Expert Review of Anticancer Therapy is a MEDLINE-indexed, international journal ...